The inside story on DNA 'vaccine' supply chains—Part 4

Where is the Regulatory Authority Inspection of Wyeth BioPharma???

Now it’s Pfizer’s turn

Part 1 -3 told us that BioNTech and Moderna are virtual companies with no capability to develop and manufacture medicinal products, especially gene therapies. We also learnt that FDA inspectors had given two of the contract organisations manufacturing the injections a real slating that should have resulted in them being shut down. Instead, they are still operating.

Now we move on to Pfizer, a company that also has no capability to develop its own medicinal products for patient markets, as it sold off its people and facilities able to produce cGMP (GMDP in EU) compliant products years ago.

We begin with the Rolling Review document submitted to EMA by Pfizer/BioNTech, kindly shared by the wonderful Sasha Latypova.